Lead Plaintiff Appointed in Amylyx Pharmaceuticals Case

News Page

Published April 18, 2024

A class action lawsuit was recently filed on behalf of investors in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) who allegedly suffered losses due to securities fraud by the company. The lawsuit (Shih V. Amylyx Pharmaceuticals, Inc., et al., 1:24-cv-00988-AS) is currently pending in the United States District Court for the Southern District of New York.

On April 17, 2024, Judge Arun Subramanian signed an order appointing Jeff Schryver as Lead Plaintiff and appointing Levi & Korsinsky, LLP lead counsel. A copy of the order can be viewed here.